000			02036na a2200253 4500
003			PC14221
005			20180417112924.0
008			130622s2011 xxx||||| |||| 00| 0 eng d
040			_cH12O
041			_aeng
100			_aLumbreras Bermejo, Carlos _9873 _eMedicina Interna
100			_9876 _aAguado García, José María _eEnfermedades Infecciosas
100			_aSan Juan Garrido, Rafael _9869 _eMedicina Interna
245	0	0	_aGESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients _h[artículo]
260			_bEnfermedades Infecciosas y Microbiología Clínica, _c2011
300			_a29(10):735-758.
500			_aFormato Vancouver: De la Torre-Cisneros J, Fariñas MC, Castón JJ, Aguado JM, Cantisán S, Carratalá J, et al. GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients. Enferm Infecc Microbiol Clin. 2011;29(10):735-58.
501			_aPMID: 21925772
504			_aContiene 253 referencias.
520			_aCytomegalovirus infection remains a major complication of solid organ transplantation. In 2005 the Spanish Transplantation Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) developed consensus guidelines for the prevention and treatment of CMV infection in solid organ transplant recipients. Since then, numerous publications have clarified or questioned the aspects covered in the previous document. These aspects include the situations and populations who must receive prophylaxis and its duration, the selection of the best diagnosis and monitoring technique and the best therapeutic strategy. For these reasons, we have developed new consensus guidelines to include the latest recommendations on post-transplant CMV management based on new evidence available.
710			_96 _aServicio de Medicina Interna
856			_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc14221.pdf _ySolicitar documento
942			_2ddc _cART _n0
999			_c14221 _d14221